Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Vistagen Therapeutics, Inc. due to alleged violations of federal securities laws related to misleading statements about its Phase 3 PALISADE-3 trial of fasedienol for social anxiety disorder [4][6]. Group 1: Company Overview - Vistagen Therapeutics, Inc. is a company listed on NASDAQ under the ticker VTGN [4]. - The company is developing fasedienol, an investigational pherine candidate aimed at treating social anxiety disorder [6]. Group 2: Legal Investigation - The law firm Faruqi & Faruqi is encouraging investors who purchased Vistagen securities between April 1, 2024, and December 16, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Vistagen, with a deadline of March 16, 2026, for investors to seek the role of lead plaintiff [4][8]. Group 3: Trial Results and Impact - On December 17, 2025, Vistagen announced that its PALISADE-3 study did not meet its primary efficacy endpoint, reporting no statistically significant improvement in anxiety reduction compared to placebo [7]. - Following the announcement, Vistagen's stock price fell by $3.50, or 80.27%, closing at $0.86 [7]. Group 4: Investor Communication - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Vistagen's conduct [9].

Core Viewpoint - A class action lawsuit has been filed against Enphase Energy, Inc. for allegedly making false and misleading statements regarding its financial and operational prospects during the Class Period from April 22, 2025, to October 28, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Enphase overstated its ability to manage channel inventory and mitigate the effects of the termination of the Residential Clean Energy Credit, leading to materially false public statements [5]. - Investors who purchased Enphase securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by April 20, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

New York, New York--(Newsfile Corp. - February 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025 and October 28, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026.SO WHAT: If you purchased Enphase securities during the Class Period ...

SAN FRANCISCO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- On February 17, 2026, Kyndryl Holdings, Inc. (NYSE: KD) filed two amended quarterly reports and one amended annual report providing further detail about problems previously reported on February 9, 2026. The recent filings reveal that “the Company’s disclosure controls and procedures and internal control over financial reporting were ineffective” as of March 31, June 30, and September 30, 2025. Each specified that “senior finance executives failed to set an ap ...

New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025 and October 28, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026.SO WHAT: If you purchased Enphase securities during the Class Period ...

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Oregon on behalf of all persons or entities who purchased or otherwise acquired NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) securities between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”). The Complaint alleges that Defendants failed to disclose to investors that: (a) that ENTR ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Vistagen To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Vistagen between April 1, 2024 and December 16, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Faruqi & Far ...

Core Viewpoint - A class action lawsuit has been filed against BlackRock TCP Capital Corp. for allegedly making materially false and misleading statements regarding its business operations and financial health during the specified Class Period from November 6, 2024, to January 23, 2026 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that BlackRock TCP's investments were not being valued appropriately, leading to understated unrealized losses and overstated net asset value (NAV) [5]. - Defendants allegedly failed to disclose critical information about the company's portfolio restructuring efforts and their ineffectiveness in resolving credit challenges [5]. - The misleading statements made by the defendants resulted in damages to investors when the true financial condition of BlackRock TCP became known [5]. Group 2: Participation Information - Investors who purchased BlackRock TCP securities during the Class Period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by April 6, 2026, to represent the interests of the class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm, which is leading the class action, has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 alone [4]. - The firm has been recognized for its success in securities class action settlements and has consistently ranked among the top firms in this area since 2013 [4].

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Paysafe Limited (NYSE: PSFE) between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2026. SO WHAT: If you purchased Paysafe securities during the Class Period you may be entitled to ...

SAN FRANCISCO, Feb. 16, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Kyndryl Holdings, Inc. (NYSE: KD) and seeks to represent investors who purchased or otherwise acquired Kyndryl securities between August 7, 2024 and February 9, 2026. The lawsuit follows the sharp selloff in Kyndryl shares (-$12.90, -55%) on February 9, 2026, after the company announced that it would not timely file its quarterly report for the quarter ended December 31, 2025, material internal control ...